Swiss biotech Actelion hits record high on potential Shire bid
Shire said to be considering a $18bn takeover of Swiss group to boost rare diseases business
Shire said to be considering a $18bn takeover of Swiss group to boost rare diseases business
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices